Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Urinary Diversion (eBook)

Siamak Daneshmand (Herausgeber)

eBook Download: PDF
2017 | 1st ed. 2017
X, 185 Seiten
Springer International Publishing (Verlag)
978-3-319-52186-2 (ISBN)

Lese- und Medienproben

Urinary Diversion -
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book offers a detailed description of various forms of urinary diversions, including the ileal conduit, orthotopic neobladder, and a variety of continent cutaneous diversions with specific focus on the techniques of reconstruction, appropriate patient selection, and management of common complications. The book also includes chapters on management of complications encountered with various forms of diversion. There are also chapters devoted to quality of life following urinary diversion and well as future perspectives.

 Urinary Diversion will be of great value for the urologist in training or in practice who wishes to not only expand the repertoire of urinary diversions offered to patients but also refine techniques of managing common complications.  


Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University and was then recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director.

Dr. Daneshmand's main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience with radical cystectomy and continent urinary diversion. His main research interests focus on the use of pathways to improve peri-operative outcomes following radical cystectomy, use of serum and molecular markers and new technologies in diagnosis and management of bladder cancer, as well as functional outcomes following continent urinary diversion.  He is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy and his protocol has significantly reduced hospital stay while improving the patient experience. He serves on the editorial board of the Bladder Cancer Journal, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the American Urological Society/ Society of Urologic Oncology Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the 'America's Top Cancer Doctors' for numerous consecutive years.  He is an active member of the Society of Urologic Oncology, has presented over 300 abstracts at scientific meetings and has authored over 200 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University and was then recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience with radical cystectomy and continent urinary diversion. His main research interests focus on the use of pathways to improve peri-operative outcomes following radical cystectomy, use of serum and molecular markers and new technologies in diagnosis and management of bladder cancer, as well as functional outcomes following continent urinary diversion.  He is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy and his protocol has significantly reduced hospital stay while improving the patient experience. He serves on the editorial board of the Bladder Cancer Journal, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the American Urological Society/ Society of Urologic Oncology Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Cancer Doctors” for numerous consecutive years.  He is an active member of the Society of Urologic Oncology, has presented over 300 abstracts at scientific meetings and has authored over 200 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.

1 Principles of Urinary Diversion2 Selection of Urinary Diversion3 Considerations for Continent Diversion in Women4 Orthotopic Diversion in Men5 Orthotopic Diversion in Women6 Continent Cutaneous Diversion7 Management of Cutaneous Stomal Complications8 Management of Complications of Ileal Conduit Stoma9 Robotic Intracorporeal Urinary Diversion10 Use of Regenerative Tissue for Urinary Diversion11 Long-term Complications of Urinary Diversion12 Health Related Quality of Life with Urinary Diversion13 Considerations for Urinary Re-Diversion 

Erscheint lt. Verlag 20.4.2017
Zusatzinfo X, 185 p. 48 illus., 41 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete
Schlagworte continent diversion • cutaneous stomal complications • ileal conduit stoma • Orthotopic diversion • urinary re-diversion
ISBN-10 3-319-52186-1 / 3319521861
ISBN-13 978-3-319-52186-2 / 9783319521862
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 7,1 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

eBook Download (2023)
Ecomed (Verlag)
CHF 97,65